μ-Chlorido-bis{[1-benzyl-3-(2,4,6-trimethylphenyl)imidazol-2-ylidene-κ<i>C</i>]silver(I)} chloride 1,2-dichloroethane hemisolvate
The title compound, [Ag<sub>2</sub>(C<sub>19</sub>H<sub>20</sub>N<sub>2</sub>)<sub>4</sub>]Cl·0.5C<sub>2</sub>H<sub>4</sub>Cl<sub>2</sub>, can be readily generated by treatment of (1-benzyl-3-(2,4,6-tri-methyl-phen-yl)imidazolium chloride with sodium bis-(tri-methyl-sil-yl)amide followed by silver chloride. The mol-ecular structure of the compound was confirmed using NMR spectroscopy and single-crystal X-ray diffraction analysis. The crystal structure of the title compound at 110 K has monoclinic (<i>P</i>2<sub>1</sub>/<i>c</i>) symmetry. The represented silver compound is of inter-est with respect to anti-bacterial properties and the structure displays a series of weak inter-molecular hydrogen-bonding inter-actions with the chloride counter-anion.
Authors
- Kuppuswamy Arumugam (ORCID: https://orcid.org/0000-0003-2654-5001)
- Kotiba A. Malek (ORCID: https://orcid.org/0000-0002-9326-3859)
Institutions
- Wright State University (US)
Publication Details
- Journal
- IUCrData
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1107/s2414314624008617
- Citations
- 1
- Primary Topic
- N-Heterocyclic Carbenes in Organic and Inorganic Chemistry
- Type
- article
- Field-Weighted Citation Impact
- 0.25
Funders
- National Institutes of Health
- American Chemical Society Petroleum Research Fund
- National Cancer Institute